Art. 22a Directive (EU) 2001/83

In forcesince 20 Jan 2011cited 8×
1.

After the granting of a marketing authorisation, the national competent authority may impose an obligation on the marketing authorisation holder:

(a)

to conduct a post-authorisation safety study if there are concerns about the risks of an authorised medicinal product. If the same concerns apply to more than one medicinal product, the national competent authority shall, following consultation with the Pharmacovigilance Risk Assessment Committee, encourage the marketing authorisation holders concerned to conduct a joint post-authorisation safety study;

(b)

to conduct a post-authorisation efficacy study when the understanding of the disease or the clinical methodology indicate that previous efficacy evaluations might have to be revised significantly. The obligation to conduct the post-authorisation efficacy study shall be based on the delegated acts adopted pursuant to Article 22b while taking into account the scientific guidance referred to in Article 108a.

The imposition of such an obligation shall be duly justified, notified in writing, and shall include the objectives and timeframe for submission and conduct of the study.

2.

The national competent authority shall provide the marketing authorisation holder with an opportunity to present written observations in response to the imposition of the obligation within a time limit which it shall specify, if the marketing authorisation holder so requests within 30 days of receipt of the written notification of the obligation.

3.

On the basis of the written observations submitted by the marketing authorisation holder, the national competent authority shall withdraw or confirm the obligation. Where the national competent authority confirms the obligation, the marketing authorisation shall be varied to include the obligation as a condition of the marketing authorisation and the risk management system shall be updated accordingly.

  • Directive (EU) 2010/84Law

    … přijímat akty v přenesené pravomoci v souladu s článkem 290 Smlouvy o fungování EU, pokud jde o doplnění článků 21a a 22a směrnice 2001/83/ES. Komise by měla být zmocněna přijmout dodatečná opatření, v nichž budou …

  • Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance o…36Law

    … na základě povinností uložených příslušným vnitrostátním orgánem, agenturou nebo Komisí v souladu s články 21a a 22a směrnice 2001/83/ES a s články 10 a 10a nařízení (ES) č. 726/2004. 2. Držitel rozhodnutí o …

  • Regulation (EU) 2024/568Law

    … (CE) no 726/2004, des études de sécurité postautorisation visées à l’article 21 bis, point b), ou à l’article 22 bis, paragraphe 1, point a), de la directive 2001/83/CE, ou à l’article 9, paragraphe 4, point c ter), ou à …

  • Commission Delegated Regulation (EU) No 357/2014 of 3 February 2014 supplementing Direct…1Law

    … artikel 21a, litra f), artikel 22a, stk. 1, litra b), i direktiv 2001/83/EF og artikel 9, stk. 4, litra cc), og artikel 10a, stk. 1, litra b), i forordning (EF) nr. 726/2004 a) hvis der er bekymring om visse aspekter af lægemidlets …

  • Gesetz über den Verkehr mit Arzneimitteln28Law

    … werden müssen; die Verpflichtung, diese Wirksamkeitsstudie nach der Zulassung durchzuführen, muss den Vorgaben nach Artikel 22a Absatz 1 Buchstabe b Satz 2 der Richtlinie 2001/83/EG entsprechen. Liegen die Voraussetzungen für eine …

  • Arrêt du Tribunal (cinquième chambre) du 11 décembre 2014. PP Nature-Balance Lizenz GmbH contre Commission européenne.Decision

    … Klagegrund macht die Klägerin geltend, die Kommission habe den Grundsatz der Verhältnismäßigkeit verletzt und Art. 22a Abs. 1 Buchst. b der Richtlinie 2001/83 verkannt, indem sie die Änderung der Zulassungen veranlasst habe, statt …

    11 Dec 2014 · 62013TJ0189

  • Commission Delegated Regulation (EU) No 357/2014 of 3 February 2014 supplementing Direct…1Law

    … a post-authorisation efficacy study to be carried out by the holder of a marketing authorisation in accordance with Articles 21a(f) and 22a(1)(b) of Directive 2001/83/EC and Articles 9(4)(cc) and 10a(1)(b) of Regulation (EC) No …

  • Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance o…36Law

    … holder under obligations imposed by a national competent authority, the Agency or the Commission in accordance with Articles 21a and 22a of Directive 2001/83/EC and Articles 10 and 10a of Regulation (EC) No 726/2004. 2. The marketing …